ERBB2 and breast carcinoma: For example, up-regulation of erbb2 expression in presence of hormonal therapy (e.g. tamoxifen) leads to tamoxifen-resistant breast cancer (Knowlden et al., 2003; Gee et al., 2005; Hurtado et al., 2008; Yonesaka et al., 2011).